23-seleno-25-homotaurocholic acid has been researched along with Bile Duct Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Merrick, MV; Ross, HM; Simpson, JD; Soundy, RG | 1 |
| Chazouillères, O; Haniche, M; Jian, R; Marteau, P; Poupon, R | 1 |
1 trial(s) available for 23-seleno-25-homotaurocholic acid and Bile Duct Obstruction
| Article | Year |
|---|---|
Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
Topics: Alkaline Phosphatase; Bile Acids and Salts; Cholestasis; Chronic Disease; Down-Regulation; Female; gamma-Glutamyltransferase; Humans; Ileum; Intestinal Absorption; Liver Cirrhosis; Male; Middle Aged; Selenium Radioisotopes; Taurocholic Acid; Up-Regulation; Ursodeoxycholic Acid | 1996 |
1 other study(ies) available for 23-seleno-25-homotaurocholic acid and Bile Duct Obstruction
| Article | Year |
|---|---|
Absorbed dose to man from the Se-75 labeled conjugated bile salt SeHCAT: concise communication.
Topics: Administration, Oral; Animals; Body Burden; Cholestasis; Energy Transfer; Gallbladder; Humans; Injections, Intravenous; Mice; Radiation Dosage; Radioisotopes; Rats; Selenium; Taurocholic Acid; Time Factors; Tissue Distribution; Whole-Body Counting | 1982 |